1 / 4

Australian Female Infertility Diagnosis And Treatment Market Size, Share and Forecast 2019-2025

Australian female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 3.8% during the forecast period. The inability to conceive may occur in both men and women, however, infertility among women is more common. There are several factors that cause infertility among women such as exceeding 35 years of age, unhealthy lifestyle and genetic disorders. The market is driven by the growth in the number of infertility cases along with the extensive development of advanced technologies such as Assisted Reproductive Technology (ART) and Intrauterine Insemination (IUI).

DIGITALG9
Download Presentation

Australian Female Infertility Diagnosis And Treatment Market Size, Share and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Asia-Pacific Female Infertility Diagnosis And Treatment Market Size, Share, Trends & Forecast 2019-2025 Request a Free Sample of Asia-Pacific Female Infertility Diagnosis And Treatment Market: https://www.omrglobal.com/request-sample/asia-pacific-female-infertility-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

  2. Asia-Pacific female infertility diagnosis and treatment market is expected to witness a significant growth rate during the forecast period. Medical tourism in this region is also growing at a faster pace owing to the quality of the healthcare services and its cost-effectiveness. According to the Healthcare Information and Management Systems Society of Asia-Pacific, medical tourism is a fast-growing industry, with an increasing number of patients seeking affordable or specialized treatment outside their home countries. Asia-Pacific is one of the considerable regions in the world for medical tourism and has developed a niche for affordable and high-quality healthcare, particularly in markets such as Thailand, India and Singapore which account for 90 % of medical tourism in Asia-Pacific. Request a Free Sample of our Report on Asia-Pacific Female Infertility Diagnosis And Treatment Market: https://www.omrglobal.com/request-sample/asia-pacific-female- infertility-market This region is also a popular Wellness Tourism destination for travelers seeking a holiday that combines yoga, meditation, spa treatments or other wellness-related pursuits. According to the Global Wellness Summit, wellness tourism is projected to grow around 9.1 % annually through 2017 which is nearly 50 % higher than that of overall global tourism. Female health services are having a major share in the medical tourism market. This will augment the female infertility diagnosis and treatment diagnosis and treatment market in the forecasted year. A full Report of Asia-Pacific Female Infertility Diagnosis And Treatment Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-female-infertility-market Asia-Pacific female infertility diagnosis and treatment market is segmented on the basis of diagnosis, treatment type, and end-user. Based on the diagnosis, the market is segmented into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (laparoscopy). Based on the treatment type, the market is segmented into drugs, surgery, intrauterine insemination (IUI), and assisted reproductive technology (ART). Based on the end-user, the market is segmented into hospitals and clinics, homecare, and pathology and diagnostic center. Market Segmentation Asia-Pacific Female Infertility Diagnosis And Treatment Market by Diagnosis Ovulation Testing

  3. Hysterosalpingography (HSG) Hysteroscopy Imaging Testing Ovarian Reserve Testing Hormonal Level Testing Genetic Testing Others (Laparoscopy) Asia-Pacific Female Infertility Diagnosis And Treatment Market by Treatment Drugs Surgery Intrauterine Insemination (IUI) Assisted Reproductive Technology (ART) Asia-Pacific Female Infertility Diagnosis And Treatment Market by End-User Hospitals and Clinics Homecare Pathology and Diagnostic Centers Regional Analysis Asia-Pacific China India Japan Rest of Asia-Pacific Company Profiles Bayer AG Pfizer Inc.

  4. Genea Ltd. Church & Dwight Co., Inc. Vitrolife Cook Medical, Inc. Eli Lilly & Co. GlaxoSmithKline Plc. Esco Group Merck KGaA For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-female-infertility-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related